EP1429732A4 - CORE FORMULATION - Google Patents

CORE FORMULATION

Info

Publication number
EP1429732A4
EP1429732A4 EP01952575A EP01952575A EP1429732A4 EP 1429732 A4 EP1429732 A4 EP 1429732A4 EP 01952575 A EP01952575 A EP 01952575A EP 01952575 A EP01952575 A EP 01952575A EP 1429732 A4 EP1429732 A4 EP 1429732A4
Authority
EP
European Patent Office
Prior art keywords
core formulation
formulation
core
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01952575A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1429732A1 (en
Inventor
Akwete L Adjei
Yaping Zhu
Anthony J Cutie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kos Life Sciences Inc
Original Assignee
Kos Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kos Life Sciences Inc filed Critical Kos Life Sciences Inc
Publication of EP1429732A1 publication Critical patent/EP1429732A1/en
Publication of EP1429732A4 publication Critical patent/EP1429732A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP01952575A 2001-07-10 2001-07-10 CORE FORMULATION Withdrawn EP1429732A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/021676 WO2003005991A1 (en) 2001-07-10 2001-07-10 A core formulation

Publications (2)

Publication Number Publication Date
EP1429732A1 EP1429732A1 (en) 2004-06-23
EP1429732A4 true EP1429732A4 (en) 2005-01-26

Family

ID=21742691

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01952575A Withdrawn EP1429732A4 (en) 2001-07-10 2001-07-10 CORE FORMULATION

Country Status (6)

Country Link
EP (1) EP1429732A4 (ja)
JP (1) JP2004536841A (ja)
AU (1) AU2001273310B2 (ja)
CA (1) CA2453784A1 (ja)
MX (1) MXPA04000176A (ja)
WO (1) WO2003005991A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2453775A1 (en) * 2001-07-10 2003-01-23 Kos Life Sciences, Inc. Core formulation comprising pioglitazone hydrochloride and a biguanide
JP2004536841A (ja) * 2001-07-10 2004-12-09 エアロファーム テクノロジー インコーポレイテッド コア製剤
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
WO2004069229A1 (en) * 2003-02-05 2004-08-19 Ipca Laboratories Limited Dual release anti-diabetic drugs and process of production thereof
WO2004091587A1 (en) * 2003-04-17 2004-10-28 Ipca Laboratories Limited Multiple release anti-diabetic drugs and process of production thereof
US20050163842A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Rosiglitazone and metformin formulations
WO2010136847A1 (en) * 2009-05-26 2010-12-02 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Coated metformin with pioglitazone solution

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6166043A (en) * 1995-06-20 2000-12-26 Takeda Chemical Industries, Ltd. Pharmaceutical composition
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
WO2001037808A1 (en) * 1999-11-23 2001-05-31 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2001082875A2 (en) * 2000-05-01 2001-11-08 Aeropharm Technology, Inc. A core formulation
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5356913A (en) * 1990-02-09 1994-10-18 The Upjohn Company Use of insulin sensitizing agents to treat hypertension
US6191162B1 (en) * 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
JP2004536841A (ja) * 2001-07-10 2004-12-09 エアロファーム テクノロジー インコーポレイテッド コア製剤

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166043A (en) * 1995-06-20 2000-12-26 Takeda Chemical Industries, Ltd. Pharmaceutical composition
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
WO2001037808A1 (en) * 1999-11-23 2001-05-31 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
WO2001082875A2 (en) * 2000-05-01 2001-11-08 Aeropharm Technology, Inc. A core formulation
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DEASY P B ET AL: "COMBINED DIPYRIDAMOLE AND ASPIRIN PELLET FORMULATION FOR IMPROVED ORAL DRUG DELIVERY. PART 1: DEVELOPMENT PHARMACEUTICS", JOURNAL OF MICROENCAPSULATION, TAYLOR AND FRANCIS INC. LONDON, GB, vol. 13, no. 4, 1 July 1996 (1996-07-01), pages 385 - 394, XP000589902, ISSN: 0265-2048 *
See also references of WO03005991A1 *

Also Published As

Publication number Publication date
CA2453784A1 (en) 2003-01-23
MXPA04000176A (es) 2004-10-27
WO2003005991A1 (en) 2003-01-23
EP1429732A1 (en) 2004-06-23
JP2004536841A (ja) 2004-12-09
AU2001273310B2 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
GB2370818B (en) A simulator
AU2001227535A8 (en) A core formulation
EP1404928A4 (en) CONSTRUCTION
AU146829S (en) A toy
AU2001227532A1 (en) A core formulation
HK1032323A2 (en) A vent-fan
AU149656S (en) A cart-housing
EP1429732A4 (en) CORE FORMULATION
AU149182S (en) A dispenser
AU153103S (en) A toothbrush
GB0104144D0 (en) a fixing plug
GB0013400D0 (en) A formulation
HK1054508A1 (zh) 新型製劑
GB2372253B (en) A render
GB0119938D0 (en) A reel
GB0109312D0 (en) A dispenser
AU143799S (en) A hatbox
AU147766S (en) A sheet-bag
AU148760S (en) A frypan
AU145394S (en) A cord-lock
AU144988S (en) A drop-bolt
AU147171S (en) A flumegate
GB0106012D0 (en) A structure
AU148454S (en) A plaque
AU148455S (en) A plaque

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040109

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20041210

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 9/50 B

Ipc: 7A 61K 31/4439 B

Ipc: 7A 61K 31/155 B

Ipc: 7A 61K 9/16 A

17Q First examination report despatched

Effective date: 20050323

17Q First examination report despatched

Effective date: 20050323

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070324